Robotics designed to help people achieve what they cannot do on their own
It all began with a question that a young engineer couldn’t get out of his head. At the École Polytechnique robotics club, Nicolas Simon watched a machine learn to walk and thought of his brother, who was losing that ability. If a robot can walk, why not create one that could walk for him?
Wandercraft was founded in Paris in 2012 to answer that question, and the answer required a decade of engineering: a self-balancing exoskeleton, so that the person wearing it doesn’t have to balance themselves. In 2019, Atalante became the first self-balancing walking exoskeleton to obtain CE marking in Europe.
That same technology is now helping people with their rehabilitation in more than 150 clinical and research centers; it’s moving from the clinic into the home with Eve; and it’s featured in Calvin, our family of humanoid robots designed for the toughest jobs in industry. Three products, two markets, one conviction: robotics should help people achieve what they cannot do on their own.
The same autonomous stabilization technology across three scales: from a clinical exoskeleton to a humanoid designed for the factory.
Our clinical exoskeleton, which enables patients to walk hands-free during rehabilitation, without crutches.
Our personal exoskeleton, designed to leave the clinic and go home with the person who walks with it.
Our humanoid robot, designed for the heaviest and most repetitive tasks in an industrial plant.
Fourteen years, three robots, and an idea that never left us. Scroll horizontally to follow it.
Nicolas Simon, Matthieu Masselin, and Jean-Louis Constanza founded Wandercraft in Paris, inspired by a brother and a son who were losing their ability to walk.
The world's first clinical trials of our prototypes show that people with paraplegia can walk hands-free, without crutches.
The world's first self-balancing exoskeleton has been approved in Europe and is helping its first patients walk in rehabilitation centers.
Atalante received FDA approval for stroke rehabilitation, paving the way for its entry into U.S. clinics and, the following year, for the launch of its U.S. operations.
At Paris 2024, our exoskeletons carry the Olympic and Paralympic torches, with torchbearers like Thibault Simon, the brother whose story started it all.
Our self-balancing personal exoskeleton is entering the testing phase with people with spinal cord injuries at the Bronx VA and at Kessler.
Renault Group has acquired a stake in the company and joined as an industrial partner, alongside a Series D funding round to scale up production worldwide.
Building on more than a decade of exoskeleton engineering, Calvin's first prototype takes shape in 40 days. Calvin-40 is unveiled with the Renault Group as its first customer.
Calvin-40 is already in operation on the production line at the Renault plant in Douai, with a fleet of 350 robots scheduled to be deployed by 2027.
Eve has become the first self-balancing personal exoskeleton approved for home use by people with spinal cord injuries.
More than 175 leading experts in artificial intelligence, robotics, and industry, working from our dual headquarters in Paris and New York.
We don't just hire people. We build a team of pioneers, curious minds, and go-getters who want to change the world, one step at a time.
Submit your application
Our Paris office has its own dance studio; there’s another one in New York, and we’re opening more locations across the United States. People train in the building every day, so no one here has to guess who we work for.
Full-body scanning, integrated artificial intelligence, certifiable security, robots that transport people and robots that carry loads, and a production line waiting for a response.
Our internal Expert Track program allows engineers to specialize in a particular field rather than advance through management. Here, seniority isn't measured solely by the number of people under their supervision.
Paris and New York, deliberately brought together: company-wide events every year and wellness commitments that we put in writing.
Come help shape the next generation of medical and humanoid robotics, driven by artificial intelligence and a sense of purpose.
